Thursday, May 5 |
|
| 10:00 am – 10:05 am | Welcome Remarks |
| 10:05am – 10:50am | Uterine Mesenchymal Tumors: What Does Ancillary Molecular Testing Add? – Dr. Teri Longacre, Stanford University, USA |
| 10:50 am – 11:00am | Question and Answer |
| 11:00am – 11:45am | Interest of multiplexed immunohistochemistry in thoracic pathology – Dr. Marius Ilié, University of Nice, France |
| 11:45pm – 12:00pm | Question and Answer |
| 12:00pm – 12:15pm | Coffee Break |
| 12:15pm – 12:30pm | Case Intro |
| 12:30pm – 12:45pm | Case 1: Vascular Tumor of the Liver: A Mimicker of Adenocarcinoma – Dr. ZuHua Gao, University of British Columbia, Canada |
| 12:45pm – 1:00pm | Case Discussion and Questions from the Audience |
| 1:00pm – 1:45pm | Practical PD-L1 Immunohistochemistry Assessment Moving from Tumor Proportion Score to Combined Positive Score – Dr. Pierre Fiset, McGill University, Canada |
| 1:45pm – 2:00pm | Question & Answer |
| 2:00pm – 2:05pm | Closing Remarks |
Friday, May 6 |
|
| 10am – 10:05am | Welcoming Remarks |
| 10:05am – 11:45am | Maximizing MMR Testing – From IHC to molecular stratification in GI and Gyne Tumours – Dr. David Schaeffer, University of British Columbia, Canada & Dr. Mary Kinloch, University of Saskatchewan, Canada |
| 11:45am – 12:00pm | Question and Answer |
| 12:00pm – 12:15pm | Coffee Break |
| 12:15pm – 12:45pm | Case 2: Perniosis mimicking T cell lymphoma in a pediatric patient – Dr. Gabriela Gheorghe, Saint Jude Children’s Research Hospital, USA |
| 12:45pm – 1:00pm | Case Discussion and Questions from the Audience |
| 1:00pm – 1:45pm | Metastatic Dedifferentiated Malignancies with Focus on Melanoma and the Value of Genotyping – Dr. Abbas Agaimy, University of Erlangen, Germany |
| 1:45pm – 2:00pm | Question and Answer |
| 2:00pm – 2:05pm | Closing Remarks |